Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market

The Asia Pacific infant, child, and maternal probiotic supplements market is expected to grow from US$ 201.82 million in 2022 to US$ 346.65 million by 2028; it is estimated to grow at a CAGR of 9.4% from 2022 to 2028.

 Many prominent manufacturers of probiotics are investing in research and development to develop reliable and science-backed probiotic supplements for infants and pregnant women. Further, they are conducting research to gain a deeper understanding of probiotics' benefits for infants, children, and expecting mothers. New research published in the Journal Microorganisms stated that probiotic supplementation during late pregnancy or lactation and breastfeeding could reduce the risk of mastitis. Similarly, in April 2019, DSM, a major food and nutritional ingredient manufacturer, conducted a study on the effects of probiotic supplementation in reducing infant colic in breastfed babies. BioCare, a fully owned subsidiary of DSM, funded this study and used probiotic strains, namely Lactobacillus rhamnosus and Lactobacillus reuteri, on breastfed babies aged 4 to 12 weeks for 28 days. The study found that breastfed babies supplemented with probiotics were less exposed to colic. The overall cry and fuss time was reduced by 163 minutes.

With the growing demand for infant and maternal probiotics products, manufacturers are innovating their products to increase their customer base and boost revenues. They are launching convenient probiotic delivery formats, such as drops, sticks, sachets, gummies, and powder, for easy consumption by infants and toddlers. These convenient delivery formats of probiotic supplements are gaining high acceptance in Asia Pacific. Thus, such R&D activities and growing studies on probiotic supplements are expected to boost the infant, child, and maternal probiotic supplements market growth over the forecast period.

With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Asia Pacific infant, child, and maternal probiotic supplements market growth at a notable CAGR during the forecast period.

 Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market Revenue and Forecast to 2028 (US$ Thousand)

Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market Segmentation  

The market for Asia Pacific infant, child, and maternal probiotic supplements market  is segmented into form, end user, and country. Based on form, the market is categorized into capsules and soft gels, gummies, liquid, and others. Based on end user, the market is segmented into infant and toddler, children, and maternal women. Based on country, the Asia Pacific infant, child, and maternal probiotic supplements market is segmented into China, Japan, Australia, New Zealand, and the Rest of Asia Pacific.

Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market —Companies Mentioned

Bayer Corporation, Nestlé S.A., BioGaia AB, and Nordic Naturals are a few major companies operating in the Asia Pacific infant, child, and maternal probiotic supplements market.

Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market Strategic Insights

Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market Segmentation Analysis

Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market Report Highlights

Asia Pacific Infant, Child, and Maternal Probiotic Supplements Report Scope

Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market Country and Regional Insights